SCHEMBL4584802

SCHEMBL4584802

CCCCCCCCCCC(C)=CC(Cl)I

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.39
ALDH1A1 P00352 3/20 0.39
FAAH O00519 1/20 0.38
CES2 O00748 3/20 0.37
CES1 P23141 3/20 0.37
GPR84 Q9NQS5 7/20 0.35
PPARG P37231 7/20 0.35
PPARD Q03181 7/20 0.35
PPARA Q07869 7/20 0.35
HDAC11 Q96DB2 5/20 0.35
PTPN1 P18031 3/20 0.35
TLR2 O60603 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
FABP4 P15090 2/20 0.35
SLC22A6 Q4U2R8 1/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
MEN1 O00255 1/20 0.35
ESR1 P03372 1/20 0.35
ALOX15 P16050 1/20 0.35
PDE4A P27815 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28632205 0.82 TSHR (0.40) TSHRALDH1A1FAAHCES2CES1
SCHEMBL11076224 0.74 TSHR (0.45) TSHRALDH1A1CES2CES1GPR84
SCHEMBL11076227 0.74 TSHR (0.45) TSHRALDH1A1CES2CES1GPR84
SCHEMBL19480573 0.73 LMNA (0.38) TSHRALDH1A1FAAHCES2CES1
SCHEMBL8520818 0.72 MAPT (0.37) FAAHCES2CES1MEN1KMT2A
SCHEMBL8520817 0.72 MAPT (0.37) FAAHCES2CES1MEN1KMT2A
SCHEMBL10516287 0.72 CES2 (0.50) TSHRALDH1A1CES2CES1GPR84
SCHEMBL1173873 0.71 CES2 (0.48) TSHRALDH1A1CES2CES1GPR84
SCHEMBL5613360 0.71 CES2 (0.48) TSHRALDH1A1CES2CES1GPR84
SCHEMBL5613328 0.71 CES2 (0.48) TSHRALDH1A1CES2CES1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613585-A4 COMPOUNDS AND METHODS FOR USE IN TREATING NEOPLASIA AND CANCER BASED UPON INHIBITORS OF ISOPRENYLCYSTEINE METHYLTRANSFERASE PURDUE RESEARCH FOUNDATION (US) 2008-07-23 EP disclosed
EP-1613585-A2 COMPOUNDS AND METHODS FOR USE IN TREATING NEOPLASIA AND CANCER BASED UPON INHIBITORS OF ISOPRENYLCYSTEINE METHYLTRANSFERASE PURDUE RESEARCH FOUNDATION (US) 2006-01-11 EP disclosed
WO-2004087064-A2 COMPOUNDS AND METHODS FOR USE IN TREATING NEOPLASIA AND CANCER BASED UPON INHIBITORS OF ISOPRENYLCYSTEINE METHYLTRANSFERASE PURDUE RESEARCH FOUNDATION (US) 2004-10-14 WO disclosed